
Sign up to save your podcasts
Or


Transcription factors are proteins that regulate the transcriptional process of genes, containing one or more specific DNA binding domains that bind to DNA sequences in the vicinity of genes.
Antibody mRNAs don't require nuclear localisation to mediate protein translation, but can be translated directly into target proteins or immunogenic activation of the immune response in vivo by using genetic sequence of the virus.
Probiotics and Immune System Modulation
Probiotics have been revealed to act as an immune modulator that plays an essential role in modulation or enhancement of the immune response.
Stress response profiling is a method to investigate NGPs’ viability and endurance, and has important guiding values for NGPs’ production. Exploration of probiotics’ stress responses to adverse conditions not only has a basic scientific motive but can also facilitate efforts to improve their performance in industrial applications.
Introduction to Bioburden Determination
Bioburden is usually defined as the population of bacteria living on an unsterilized surface. Previous studies have indicated that bioburden is a major threat to human health due to the availability of residues, such as allergens, endotoxins, or exotoxins. Moreover, many reports have revealed that bioburden can affect the stability and effectiveness of live biotherapeutic products.
Introduction to Antibiotic Susceptibility/Resistance
In recent years, live bacterial therapeutics has become a new class of regulatory approach for treating various human and animal diseases. For instance, the development of novel next-generation probiotics (NGPs) can be widely used for skin disease control with a high therapeutic effect and improved safety. However, pilot studies have indicated that most NGPs strains are susceptible to certain types of antibiotics, such as ampicillin and gentamicin, and they are not be easily eliminated if they harm the host. Moreover, the antibiotic resistance of these NGPs may subsequently spread to specific pathogenic microorganisms. As a result, a panel of assays, including antibiotic susceptibility/resistance testing, have been generated for measuring the pathogenic bacteria in clinical samples.
Stability tests for live biotherapeutic products are essential to assess sensitivity to a large range of factors that impact biologic activity, product safety, and quality.
With the progress of live biotherapeutics development, multiple microbiome or probiotics have been extensively applied for the prevention and treatment of human diseases and conditions. Currently, an increasing number of preclinical and clinical trials are underway to assess the therapeutic potential and safety of new probiotics, especially those gene engineered probiotics that do not have a long history of safe use. Probiotic microorganisms are directly orally administrated into the human body to provide a variety of beneficial and therapeutic effects. Some probiotics must be intestinal environmental resistant and antibiotic-resistant to achieve the desired therapeutic effect, which requires high safety to ensure that there will be no potential safety hazard to the body. Furthermore, the safety assessment of live biotherapeutics products in high-risk populations, such as immunocompromised individuals, deserves special attention.
Over the past few decades, a large number of live biotherapeutic products, including next-generation probiotics (NGPs), have been developed for treating various types of human and animal diseases. Meanwhile, a panel of detection systems for live biotherapeutic products have been designed and widely used for measuring the safety, efficacy, and product quality in the pharmaceutical industry.
Gene integration stability testing is a key component and a regulatory requirement for characterization live biotherapeutic products production. Genetic elements integrate transgenes into the host genome of recombinant strains in a random manner.
From the publisher's feed